These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15331071)
1. Pharmacologic management of nonalcoholic fatty liver disease. Harrison SA; Neuschwander-Tetri BA Clin Liver Dis; 2004 Aug; 8(3):715-28, xii. PubMed ID: 15331071 [TBL] [Abstract][Full Text] [Related]
2. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Younossi ZM Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557 [TBL] [Abstract][Full Text] [Related]
3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study. Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473 [TBL] [Abstract][Full Text] [Related]
4. The metabolic syndrome and nonalcoholic fatty liver disease. Collantes RS; Ong JP; Younossi ZM Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331 [TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582 [TBL] [Abstract][Full Text] [Related]
7. Weight loss as a treatment for nonalcoholic fatty liver disease. Clark JM J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766 [TBL] [Abstract][Full Text] [Related]
8. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. Gan SK; Adams LA; Watts GF Curr Opin Lipidol; 2008 Dec; 19(6):592-9. PubMed ID: 18957882 [TBL] [Abstract][Full Text] [Related]
11. The treatment of NAFLD. Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594 [TBL] [Abstract][Full Text] [Related]
15. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
16. Medical treatment of non-alcoholic steatohepatitis. Kadayifci A; Merriman RB; Bass NM Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975 [TBL] [Abstract][Full Text] [Related]
17. [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis]. Timmer A Z Gastroenterol; 2007 Feb; 45(2):191-3. PubMed ID: 17304406 [No Abstract] [Full Text] [Related]
18. Nonalcoholic fatty liver disease: pharmacologic and surgical options. Parikh N; Ahmad J Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273 [TBL] [Abstract][Full Text] [Related]
19. [Drug therapy for nonalcoholic fatty liver disease]. Shen W Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):139. PubMed ID: 15727706 [No Abstract] [Full Text] [Related]